ARTICLE | Company News
Millennium, Pharsight in software deal
July 17, 2001 7:00 AM UTC
MLNM will evaluate PHST's computer-based trial design and decision software. MLNM initially will use the technology in its clinical program for LDP-341, a proteosome inhibitor in Phase II testing for ...